We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Imaging Technique Could Improve Cancer Screening in Areas with Limited Access to PET Scans

By MedImaging International staff writers
Posted on 14 Apr 2022
Print article
Image: Cerenkov imaging of a thyroid tumor captures its location and high activity (Photo courtesy of MSK)
Image: Cerenkov imaging of a thyroid tumor captures its location and high activity (Photo courtesy of MSK)

Positron emission tomography (PET) is one of the most widely used diagnostic tools in cancer care. PET scans show the location of a tumor, usually based on increased glucose intake, a hallmark of cancer cells. Despite their effectiveness, PET scans can be hard to access in developing countries and rural areas. PET scanners are expensive and many regions lack the infrastructure required to house them and support their operation. There has been a pressing need for cheaper ways to do imaging to improve cancer care for a much larger population around the world. Now, a team of researchers has begun testing a new technology that could provide a cheaper, faster imaging approach for areas where access to PET scans is limited.

The technique being tested by researchers at Memorial Sloan Kettering Cancer Center (MSK, New York, NY, USA) involves employing specialized cameras to detect Cerenkov light, a faint glow that is naturally emitted by radioactive tracers. PET scans require these radioactive tracers to detect the increased glucose metabolism of cancer cells. The new approach could make it possible to get critical information with most clinically used radioactive tracers but without the PET machine - and at a fraction of the cost. The researchers demonstrated the effectiveness of Cerenkov light in this setting in a clinical trial of nearly 100 patients.

For five different radiotracers, Cerenkov proved to be as accurate for showing tumor location as conventional imaging methods like PET and computed tomography (CT). For some patients who were receiving radiation therapy, Cerenkov also provided information on whether their tumors were shrinking or responding in other ways to the treatment. The clinical trial was the largest study to date testing Cerenkov imaging. While it validates the technique’s potential as a cheaper and more portable imaging approach than PET, the researchers are already looking for further refinements to make it even more useful. This includes imaging the entire body (rather than specific sites), imaging during an operation to help guide surgical decisions, and using a more sensitive camera to make image acquisition even faster and easier.

“This imaging technique based on Cerenkov light could be used instead of expensive PET scans in many cases,” said Jan Grimm, a radiologist and molecular imaging specialist at MSK, who led the team. “It wouldn’t replace PET because it cannot provide the same level of detail, precise measurement, or depth penetration. But having a cheaper and faster imaging approach to select patients that should undergo a PET scan or as a first-line test could provide a huge benefit to many developing areas.”

Related Links:
Memorial Sloan Kettering Cancer Center 

Print article
Sun Nuclear



view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more


view channel
Image: fMRI can be used as non-invasive method for predicting complications in chronic liver disease (Photo courtesy of Pexels)

Functional MRI (fMRI) Offers Non-Invasive Method for Risk Assessment in Liver Disease

In a recent study, a team of scientists has shown that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease.... Read more


view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.